Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3036597

CCCCCCCCCCCCCCPCCCC.Cl

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.50
THRB P10828 1/20 0.50
DNM1 Q05193 9/20 0.43
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HSD17B10 Q99714 1/20 0.38
SLC22A1 O15245 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23499239 1.00 TSHR (0.50) TSHRTHRBDNM1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL19411922 1.00 TSHR (0.50) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL5396197 0.97 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL21900824 0.97 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL6432036 0.97 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL6432374 0.97 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL1461446 0.97 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL19411863 0.97 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL15068309 0.97 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL5389614 0.97 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11814582-B2 Friction reducers and well treatment fluids ITALMATCH CHEMICALS GB LIMITED (GB) 2023-11-14 US claimed
CN-114431227-A Biological membrane sterilization synergist, sterilization composition and biological membrane removal method 中国特种设备检测研究院 2022-05-06 CN claimed
US-20210106008-A1 BIOCIDAL COMPOSITIONS AND METHOD OF TREATING WATER USING THEREOF ITALMATCH CHEMICALS GB LIMITED (GB) 2021-04-15 US claimed
US-10905125-B2 Biocidal compositions and method of treating water using thereof Italmatch Chemicals Gb Ltd. (GB) 2021-02-02 US claimed
US-20210022346-A1 RELATING TO WATER TREATMENT BWA WATER ADDITIVES UK LIMITED (GB) 2021-01-28 US claimed
US-10827758-B2 Relating to water treatment ITALMATCH CHEMICALS GB LIMITED (GB) 2020-11-10 US claimed
US-20200040526-A1 BIOCIDAL COMPOSITIONS ITALMATCH CHEMICALS GB LIMITED (GB) 2020-02-06 US claimed
US-10480125-B2 Biocidal compositions BWA WATER ADDITIVES UK LIMITED (GB) 2019-11-19 US claimed
US-20190144742-A1 FRICTION REDUCERS AND WELL TREATMENT FLUIDS ITALMATCH CHEMICALS GB LIMITED (GB) 2019-05-16 US claimed
US-20190142002-A1 AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2019-05-16 US claimed
US-20160100584-A1 RELATING TO WATER TREATMENT ITALMATCH CHEMICALS GB LIMITED (GB) 2016-04-14 US claimed
US-20160102002-A1 WATER TREATMENT ITALMATCH CHEMICALS GB LIMITED (GB) 2016-04-14 US claimed
US-20150126479-A1 AQUEOUS SOLUTIONS OF 1,2-BENZISOTHIAZOLIN-3-ONE ISP INVESTMENTS INC. (US) 2015-05-07 US claimed
EP-2706855-A1 AQUEOUS SOLUTIONS OF 1,2-BENZISOTHIAZOLIN-3-ONE Isp Investments Inc. (US) 2014-03-19 EP claimed
WO-2012158425-A1 AQUEOUS SOLUTIONS OF 1,2-BENZISOTHIAZOLIN-3-ONE ISP INVESTMENTS INC. (US) 2012-11-22 WO claimed
WO-2010100470-A2 IMPROVEMENTS IN AND RELATING TO BIOCIDAL COMPOSITIONS BWA WATER ADDITIVES UK LIMITED (GB) 2010-09-10 WO claimed
US-20100226874-A1 BIOCIDAL COMPOSITIONS ITALMATCH CHEMICALS GB LIMITED (GB) 2010-09-09 US claimed
US-4835143-A WATER TREATMENT BETZ LABORATORIES, INC. (US) 1989-05-30 US claimed
US-4835144-A WATER TREATMENT BETZ LABORATORIES, INC. (US) 1989-05-30 US claimed
US-4725587-A PAPERMAKING AND PULPING; WATER SYSTEMS; COOLING BETZ LABORATORIES, INC. (US) 1988-02-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190142002-A1 AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF MYD88, C9, PARN TSHR 3417/4885THRB 3511/4885DNM1 515/4885
US-10480125-B2 Biocidal compositions C9, PHOSPHO1, BRI3BP TSHR 2470/4885THRB 1923/4885DNM1 3367/4885
US-20160102002-A1 WATER TREATMENT PHOSPHO1, IPMK, PPIP5K2 TSHR 1025/4885THRB 711/4885DNM1 898/4885
US-20160100584-A1 RELATING TO WATER TREATMENT PHOSPHO1, PPA1, PPIP5K2 TSHR 1105/4885THRB 602/4885DNM1 910/4885
US-20200040526-A1 BIOCIDAL COMPOSITIONS C9, PHOSPHO1, BRI3BP TSHR 2470/4885THRB 1923/4885DNM1 3367/4885
US-20100226874-A1 BIOCIDAL COMPOSITIONS C9, PHOSPHO1, BRI3BP TSHR 2470/4885THRB 1923/4885DNM1 3367/4885
US-20210106008-A1 BIOCIDAL COMPOSITIONS AND METHOD OF TREATING WATER USING THEREOF PPP1CC, DKC1, WNK1 TSHR 1829/4885THRB 321/4885DNM1 3217/4885
US-20210022346-A1 RELATING TO WATER TREATMENT PHOSPHO1, POLI, AQP1 TSHR 1625/4885THRB 741/4885DNM1 2432/4885
US-10905125-B2 Biocidal compositions and method of treating water using thereof PHOSPHO1, CAT, BPGM TSHR 3824/4885THRB 1647/4885DNM1 721/4885
US-10827758-B2 Relating to water treatment PHOSPHO1, PPA1, PPIP5K2 TSHR 1105/4885THRB 602/4885DNM1 910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.